causal

US Market Subsidizes Global Drug Innovation

Because foreign governments negotiate drug prices down to near cost while the United States allows manufacturers to charge monopoly prices (with Medicare barred from negotiating), 50% or more of a new drug's profits come from the US market, making the rest of the world free-riders on American consumers who fund the innovation.

causalpending

Speaker

Russ Roberts

Evidence Quote

“we here in Israel and elsewhere around the world are free-riding on the only place where manufacturers can make money.”

Source

Casey Mulligan on Vaccines, the Pandemic, and the FDA— EconTalk
Created: 6/13/2026, 12:24:14 AM

Your notes

Loading notes...